Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

RYSE vs. FQTEX: which is better?

Bottom line

RYSE vs FQTEX: the short answer

RYSE (Vest 10 Year Interest Rate Hedge ETF) and FQTEX (Franklin Templeton SMACS: Series E) are both etfs.

FQTEX is cheaper at 0% vs 0.94% — a difference of $94 a year per $10,000 invested.

Over one year, FQTEX returned +11.4% vs −3.8% for RYSE (reporting dates differ).

Updated Nov 19, 2026

RYSE vs FQTEX side by side

RYSEFQTEX
TypeETFMutual fund
Fund familyGrayscaleFranklin Templeton
CategoryOtherOther
Expense ratio0.94%0%
Annual cost per $10k$94$0
10-yr cost on $10k (prospectus)$1,155$94
Max front loadNone—
12b-1 fee0%0%
1-yr return−3.8%+11.4%
5-yr return (annualized)—+9.8%
10-yr return (annualized)——
Best quarter+13.1%+15.2%
Worst quarter−10.7%−23.2%
Net assets (fund)—$626.0M
Number of holdings—114
Portfolio turnover%103%
Returns as ofDec 31, 2025Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearRYSEFQTEXDifference
2024+14.1%+11.4%+2.7%

Source: Fund prospectus bar charts

Holdings overlap

RYSE and FQTEX share none of their top holdings.

RYSE top 10

    FQTEX top 10

    1. Ares Management Corp. — 4.35%
    2. Boeing Co. (The) — 3.63%
    3. NextEra Energy, Inc. — 3.16%
    4. Shell plc — 3.04%
    5. Albemarle Corp. — 2.49%
    6. Medtronic plc — 2.36%
    7. UnitedHealth Group, Inc. — 2.13%
    8. Philip Morris International, Inc. — 1.91%
    9. TotalEnergies SE — 1.81%
    10. McDonald's Corp. — 1.78%

    FAQ

    What is the difference between RYSE and FQTEX?
    RYSE (Vest 10 Year Interest Rate Hedge ETF) and FQTEX (Franklin Templeton SMACS: Series E) are both etfs. FQTEX is cheaper at 0% vs 0.94% — a difference of $94 a year per $10,000 invested.
    Which is cheaper, RYSE or FQTEX?
    FQTEX has the lower expense ratio (0%).
    Should I own both RYSE and FQTEX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.